Anti-SLC39A12 monoclonal antibody

Pre-made anti-SLC39A12 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SLC39A12/SLC39A12 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1735-Ab-1/ GM-Tg-hg-IP1735-Ab-2Anti-Human SLC39A12 monoclonal antibodyHuman
GM-Tg-rg-IP1735-Ab-1/ GM-Tg-rg-IP1735-Ab-2Anti-Rat SLC39A12 monoclonal antibodyRat
GM-Tg-mg-IP1735-Ab-1/ GM-Tg-mg-IP1735-Ab-2Anti-Mouse SLC39A12 monoclonal antibodyMouse
GM-Tg-cynog-IP1735-Ab-1/ GM-Tg-cynog-IP1735-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC39A12 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1735-Ab-1/ GM-Tg-felg-IP1735-Ab-2Anti-Feline SLC39A12 monoclonal antibodyFeline
GM-Tg-cang-IP1735-Ab-1/ GM-Tg-cang-IP1735-Ab-2Anti-Canine SLC39A12 monoclonal antibodyCanine
GM-Tg-bovg-IP1735-Ab-1/ GM-Tg-bovg-IP1735-Ab-2Anti-Bovine SLC39A12 monoclonal antibodyBovine
GM-Tg-equg-IP1735-Ab-1/ GM-Tg-equg-IP1735-Ab-2Anti-Equine SLC39A12 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1735-Ab-1/ GM-Tg-hg-IP1735-Ab-2; GM-Tg-rg-IP1735-Ab-1/ GM-Tg-rg-IP1735-Ab-2;
GM-Tg-mg-IP1735-Ab-1/ GM-Tg-mg-IP1735-Ab-2; GM-Tg-cynog-IP1735-Ab-1/ GM-Tg-cynog-IP1735-Ab-2;
GM-Tg-felg-IP1735-Ab-1/ GM-Tg-felg-IP1735-Ab-2; GM-Tg-cang-IP1735-Ab-1/ GM-Tg-cang-IP1735-Ab-2;
GM-Tg-bovg-IP1735-Ab-1/ GM-Tg-bovg-IP1735-Ab-2; GM-Tg-equg-IP1735-Ab-1/ GM-Tg-equg-IP1735-Ab-2
Products NameAnti-SLC39A12 monoclonal antibody
Formatmab
Target NameSLC39A12
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SLC39A12 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1735-Ag-1Recombinant multi-species S39AC/ SLC39A12/ LZT-Hs8 protein


    Target information

    Target IDGM-IP1735
    Target NameSLC39A12
    Gene ID221074,277468,291328,701128,477989,101092444,527210,100056009
    Gene Symbol and SynonymsbA570F3.1,Gm731,LZT-Hs8,SLC39A12,ZIP-12,ZIP12
    Uniprot AccessionQ504Y0,Q08E40
    Uniprot Entry NameS39AC_HUMAN,S39AC_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000148482
    Target ClassificationN/A

    The target: SLC39A12, gene name: SLC39A12, also named as LZT-Hs8, ZIP-12, bA570F3.1. Zinc is an essential cofactor for hundreds of enzymes. It is involved in protein, nucleic acid, carbohydrate, and lipid metabolism, as well as in the control of gene transcription, growth, development, and differentiation. SLC39A12 belongs to a subfamily of proteins that show structural characteristics of zinc transporters (Taylor and Nicholson, 2003 [PubMed 12659941]).[supplied by OMIM, Aug 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.